Back to search

Article

Fluconazole in Hypercalciuric Patients with Increased 1,25(OH)2D Levels: The Prospective, Randomized, Placebo-Controlled, Double Blind FLUCOLITH Trial.

2022-01-13

Abstract excerpt

<title>Abstract</title> <p>BackgroundHypercalciuria is one of the most frequent metabolic disorders associated with nephrolithiasis and/or nephrocalcinosis possibly leading to chronic kidney disease (CKD) and bone complications in adults. Orphan diseases with different underlying primary pathophysiology share inappropriately increased 1,25(OH)<sub>2</sub>D levels and hypercalciuria, e.g., hypersensitivity to vita...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7632ce19-8658-5e17-af10-857d8c4b30da
DOI
10.21203/rs.3.rs-1003599/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Fluconazole in Hypercalciuric Patients with Increased 1,25(OH)2D Levels: The Prospective, Randomized, Placebo-Controlled, Double Blind FLUCOLITH Trial.DOI 10.21203/rs.3.rs-1003599/v1
Select a neighboring publication to make it the new centre.